Siglimepol Tablet

Produktübersicht

About Siglimepol Tablet

Siglimepol Tablet is a medication containing the active ingredient Sitagliptin, classified as Dipeptidyl Peptidase 4 Inhibitor. Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. It is in the dipeptidyl peptidase-4 (DPP-4) inhibitor class and works by increasing the production of insulin and decreasing the production of glucagon by the pancreas.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Sitagliptin, the active ingredient in Siglimepol Tablet, belongs to the Dipeptidyl Peptidase 4 Inhibitor class. 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Siglimepol Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Siglimepol Tablet for extended periods without medical advice.